TissueScan, Colon Cancer cDNA Array V

SKU
HCRT105
48 samples covering 6-normal, 3- Stage I, 14-IIA, 2-IIB, 8-IIIB, 8-IIIC, 7-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Colon Cancer cDNA Array V
Clinical Info
Diagnosis Category Colon Cancer
Tissue Colon
Shipping Ambient
Description 48 samples covering 6-normal, 3- Stage I, 14-IIA, 2-IIB, 8-IIIB, 8-IIIC, 7-IV. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

ARID3A inhibits colorectal cancer cell stemness and drug-resistance by targeting a multitude of stemness-associated genes
Gope, Pal, Srivastava et al
Life Sci (2025)
Cited by 3
AI Summary: OriGene’s TissueScan Colon Cancer cDNA Array V (Cat No. HCRT105) was used in this study to quantitatively assess ARID3A expression across various stages of colorectal cancer and normal tissues, providing essential clinical samples for the analysis.
Snippet: … HCRT105). … Clinical and pathological features of these samples are available at https://www.origene.com/catalog/tissues/tissuescan/hcrt105/tissue scan-colon cancer-cdna array-v. …
Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
Paul, Gope, Das et al
BMC Cancer (2022) 22 (1), 594 DOI: 10.1186/s12885-022-09670-6
Cited by 5
AI Summary: OriGene contributed to this study by providing the TissueScan Colon Cancer cDNA Array V (Cat No. HCRT105), which was used to analyze NOSTRIN expression across different stages of human colon cancer.
Snippet: …Methods Cell;- Clinical samples across all stages of the disease were acquired from Origene (USA) as Tissue scan colon cancer cDNA array V (Cat No. HCRT105). …
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
Lin, Zhu, Luo et al
Immun Inflamm Dis (2020)
Cited by 12
AI Summary: OriGene’s Colon Cancer cDNA array was used in this study to measure CEP55 mRNA levels in colorectal cancer tissues, helping to validate CEP55 as a potential diagnostic and prognostic biomarker for colorectal cancer.
Snippet: … Current specific diagnosis regarding CRC remains complicated and costly, and specific diagnostic b...;The elevated CEP55 messenger RNA (mRNA) was observed in CRC tissues using RT‐PCR in an OriGene Colon Cancer cDNA array (Figure 6A,B). … The results indicated that CEP55 immunoreactivity was more intense in tumors than in adjacent healthy mucosal tissues (Figure 6C,D) (p  .01). As shown in Figure 7E,F, Western blot analysis of CEP55 protein expression in paired 37 pairs of CRC tissues and adjacent tissues from humans indicated that the protein expression level of CEP55 was significantl
RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon
Yu, Culbertson, Asgharian et al
bioRxiv (2020)
Cited by 6
Snippet: … Title: RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon Authors: Johnny Yu1,2,3, , Bruce Culbertson1,2,3, , Hosseinali Asgharian1,2,3, , Albertas Navickas1,2,3, Lisa Fish1;For clinical samples, 96 samples across all stages of the disease were acquired from Origene (HCRT104 and HCRT105), 14 normal, 8 stage I, 25 stage II, 32 stage III, and 17 stage IV. …
DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis
Zhou, Liu, Zhang et al
Cell Death Dis (2018) 9 (9), 865 DOI: 10.1038/s41419-018-0883-4
AI Summary: OriGene’s Colon Cancer cDNA Array was used in this study to measure and compare DJ-1 mRNA levels in colorectal cancer tissues versus normal mucosal tissues, supporting the finding that DJ-1 is upregulated in colorectal cancer.
Snippet: The mRNA levels of DJ-1 were higher in CRC samples than that in normal mucosal tissues (Supplementary Fig. 1A). Consistently, elevated DJ-1 mRNA was also observed in CRC tissues using qRT-PCR in an OriGene Colon Cancer cDNA Array (Fig. 1a, P = 0.016)
Linc-RoR promotes c-Myc expression through hnRNP I and AUF1
Huang, Zhang, Ho et al
Nucleic Acids Res. (2015)
Cited by 116
AI Summary: OriGene's colon cancer tissue cDNA arrays were used in this study to analyze Linc-RoR expression levels by qPCR, helping to determine its role in cancer.
Snippet: Colon cancer tissue cDNA arrays were purchased from OriGene (Rockville, MD, USA). ... To determine the role of Linc-RoR in cancer, we first examined Linc-RoR expression using the colon cancer tissue cDNA arrays from OriGene by qPCR. ... Cite SaveSaving
Showing 1-6 of 18 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products